In our EV-cell imaging experiments, a comparison of two distinct breast cancer cell lines, i.e. the HER2-positive SK-BR-3 and the HER2-negative MDA-MB-231 cells, showed the same cumulative number of GFP spots upon exposure to the different recombinant EVs for a few hours. Here, ERBB2 is linked to breast carcinoma.